SCHEMBL1766100

SCHEMBL1766100

O=C1CC(c2ccc(F)cc2)CC(=O)C1C(=O)Nc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.46
GRIN2B Q13224 1/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
LMNA P02545 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TOP2A P11388 1/20 0.43
SLC22A12 Q96S37 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
USP2 O75604 1/20 0.42
HTT P42858 1/20 0.42
MAP1LC3B Q9GZQ8 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CACNA1H O95180 2/20 0.42
TSHR P16473 1/20 0.41
POLB P06746 2/20 0.41
HPGD P15428 1/20 0.41
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11161544 0.94 KMT2A (0.51) RXFP1GRIN2BKMT2AMEN1LMNA
SCHEMBL14867379 0.90 SMN1; SMN2 (0.49) GRIN2BKMT2AMEN1LMNAKDM4E
SCHEMBL11124603 0.86 MAPT (0.48) KMT2AMEN1LMNAKDM4EALDH1A1
SCHEMBL11121453 0.81 POLB (0.54) KMT2ALMNAKDM4EALDH1A1HTT
SCHEMBL11122341 0.78 KMT2A (0.51) KMT2AMEN1LMNAKDM4EALDH1A1
SCHEMBL14867389 0.78 EPHX1 (0.51) ALDH1A1HTTMAP1LC3BNPC1RAB9A
SCHEMBL11158037 0.78 ALDH1A1 (0.56) KMT2AMEN1LMNAKDM4EALDH1A1
SCHEMBL1766105 0.77 THRB (0.52) KMT2AMEN1NPC1RAB9ATSHR
SCHEMBL11122328 0.76 KMT2A (0.47) KMT2AMEN1LMNAALDH1A1USP2
SCHEMBL1782172 0.74 MAP1LC3B (0.46) KMT2AMEN1LMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US claimed
EP-2501229-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS University Of Rochester (US) 2012-09-26 EP claimed
WO-2011062964-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS UNIVERSITY OF ROCHESTER (US) 2011-05-26 WO claimed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
EP-2501229-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS University Of Rochester (US) 2012-09-26 EP disclosed
WO-2011062964-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS UNIVERSITY OF ROCHESTER (US) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms HDAC5, AADAC, SIRT1 RXFP1 3256/4885GRIN2B 4168/4885KMT2A 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.